Vall d'Hebron University Hospital

Name

Vall d'Hebron University Hospital

Legal name

Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca

Website

https://vallhebron.com

Company type

Private

Founded year

1955

Operating status

Operating

Headcount range

5,001–10,000 employees

Ownership category

akta.pro rank

Product category

Academic Medical Center Services

NAICS

General Medical and Surgical Hospitals (62211), General Medical and Surgical Hospitals (6221), General Medical and Surgical Hospitals (622110)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060)

akta.pro primary industry

Community & Regional General Hospitals (HLAFAAAB)

akta.pro secondary industries

Hospitals, Clinics & Charitable Healthcare Providers (BPAGACAB), Transplant Specialty Hospitals (HLAFAHAE)

Keywords

• University hospital services
• Biomedical research
• Clinical trials
• Medical education
• Transplant services

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Distribution channels1 record

Marketing channels7 records

Core offering

Vall d'Hebron Barcelona Hospital Campus is a public university hospital that delivers comprehensive healthcare across all medical and surgical specialties (including emergency, surgery, and transplants) while integrating biomedical research, clinical trials, and medical education across five coordinated institutions: the general hospital, VHIR, VHIO, Cemcat, and the UAB teaching unit.

Product overview

Vall d'Hebron Barcelona Hospital Campus is a leading healthcare campus comprising five institutions: Hospital Universitari Vall d'Hebron (general hospital), Vall d'Hebron Institut de Recerca (VHIR - biomedical research), Vall d'Hebron Institut d'Oncologia (VHIO - cancer research), Centre d'Esclerosi Múltiple de Catalunya (Cemcat - MS care), and the teaching unit of Universitat Autònoma de Barcelona. The campus offers integrated healthcare services, research programs, advanced clinical simulation training, and digital health tools including the El Meu Vall d'Hebron patient portal and the Espai de Dades health data platform. The Smart Campus initiative incorporates mobile technology to enhance patient and professional experience.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Achieved zero pediatric liver transplant waitlist in December 2021
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

15 partnerships are on record, tiered core and minor.

• Barcelona & Madrid Health HubcoreStrategic or Co-development Partner · 24 July 2026Vall d'Hebron and Barcelona & Madrid Health Hub renewed their collaboration agreement to support healthcare innovation and startup ecosystem development.
• Cleveland CliniccoreStrategic or Co-development Partner · 23 July 2026Vall d'Hebron instructors are accredited by the Cleveland Clinic to deliver the SEVA course, establishing a training collaboration in simulation-based medical education.
• European Reference Networks (ERNs)coreStrategic or Co-development Partner · 1 July 2026Vall d'Hebron participates in the 24 European Reference Networks, virtual networks connecting expertise across Europe for rare and complex diseases. Dr. Mar Mañú holds the presidency of the ERN Coordinators' Group TRIO.
• NSN Cycling TeamminorStrategic or Co-development Partner · 30 June 2026Vall d'Hebron and NSN Cycling Team formed a collaboration to improve injury care and recovery protocols for cycling athletes.
• Fundació KālidaminorStrategic or Co-development Partner · 12 June 2026Vall d'Hebron and Fundació Kālida joined forces to enhance psychoemotional support for people with cancer, integrating Kālida's support services within the hospital campus.
• ANiNATHminorOthers · 21 January 2025ANiNATH donated €18,000 to improve liver transplant treatments for children at Vall d'Hebron.
• European University Hospitals Alliance (EUHA)coreStrategic or Co-development Partner · 15 January 2025Vall d'Hebron is a member of EUHA, collaborating with leading European university hospitals on shared strategic initiatives including advanced therapies and healthcare innovation.
• Condis and WorldCoominorOthers · 1 January 2025Condis supermarket chain and WorldCoo platform initiated a solidarity rounding campaign to support pediatric cancer research at Vall d'Hebron.
• HipofamminorOthers · 23 December 2024Hipofam made a donation of €19,000 for research into familial hypomagnesemia, continuing a decade-long partnership with cumulative donations of €250,000.
• Ospedale San RaffaelecoreStrategic or Co-development Partner · 6 May 2022Vall d'Hebron and Ospedale San Raffaele collaborate to promote and advance health research through joint initiatives and knowledge sharing.
• Associació Endavant Chic@sminorOthers · 8 March 2017Breast cancer patient support association Endavant Chic@s collaborates with Vall d'Hebron through a volunteering agreement, providing support to breast cancer patients throughout their treatment journey.
• Cancer Core EuropecoreStrategic or Co-development PartnerVHIO participates in Cancer Core Europe consortium since 2014, a collaboration of 7 European research centers accelerating cancer research for patient benefit.
• Horizon Europe Cancer Mission (PrimeROSE, PCM4EU, CCE_DART, PragmaTIL, canSERV)coreStrategic or Co-development PartnerVHIO participates in multiple European research projects under Horizon Europe Cancer Mission to develop new therapeutic strategies for cancer patients.
• CaixaResearchcoreStrategic or Co-development PartnerCaixaResearch supports the UITM-CaixaResearch unit at VHIO for molecular cancer therapy research and early-phase clinical trials.
• Autonomous University of Barcelona (UAB)coreStrategic or Co-development PartnerUAB is part of the Vall d'Hebron Campus as the teaching unit, providing medical education and training programs.

Scale indicators13 records

Recent moves10 records

Expansion highlights5 records

Broad incumbents

• Karolinska University Hospital: Sweden's premier academic medical center, integrated with Karolinska Institutet; competes with Vall d'Hebron for European Reference Network leadership, EU research funding, and international patient referrals.
• Charité – Universitätsmedizin Berlin: One of Europe's largest university hospitals with comparable integrated research-teaching-care model; competes for EU clinical trial allocations, ERN leadership, and translational research partnerships.
• Assistance Publique – Hôpitaux de Paris (AP-HP): France's largest public university hospital network, with similar scale, multi-site structure, and academic mission; competes for EU research grants, ERN referrals, and international recognition rankings.
• King's College Hospital (Denmark Hill): Major UK NHS teaching hospital with similar tertiary/quaternary focus, transplant services, and academic research footprint; comparable for European specialty referral and clinical trial competition.

Direct peers

• Hospital Clínic de Barcelona: Leading Barcelona-based university hospital and direct competitor within Catalonia, providing comparable tertiary/quaternary care, research, and teaching activity; primary rival for Catalan patient referrals and clinical trial volume.
• Hospital Universitario La Paz: Major Madrid public university hospital with similar scope (comprehensive specialties, large research output, teaching) and competing for national CSUR designations and cross-regional referrals in Spain.
• Hospital General Universitario Gregorio Marañón: Large Madrid public university hospital offering comparable tertiary care, transplant programs, and research activity; competes with Vall d'Hebron for national CSUR designations and Spanish clinical trial share.
• Ospedale San Raffaele: Italian research hospital affiliated with Vita-Salute San Raffaele University with similar translational research focus; already a declared Vall d'Hebron joint research partner and comparable in oncology and rare disease trial activity.

Emerging players

• Memorial Sloan Kettering Cancer Center: Global oncology leader with direct comparability to VHIO's mission in cancer research, molecular therapy, and early-phase trials; competes for oncology trial sponsors and international prestige, though US-based and broader in scope.

Others

• European University Hospitals Alliance (EUHA): Consortium of leading European university hospitals (including Vall d'Hebron) collaborating on advanced therapies and innovation; relevant as a peer ecosystem rather than a competitor, shaping joint strategy and shared initiatives.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/vallhebron
• Xtwitter.com/vallhebron
• Instagraminstagram.com/vallhebron
• YouTubeyoutube.com/user/vallhebron
• LinkedInlinkedin.com/company/vall-dhebron

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vall d'Hebron University Hospital